Home
Live Updates
Regulus Therapeutics Announces Appointment of Preston S. Klassen, M.D. to its Board of Directors : vimarsana.com
Regulus Therapeutics Announces Appointment of Preston S. Klassen, M.D. to its Board of Directors
/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...
Related Keywords
United States ,
San Diego ,
California ,
Stelios Papadopoulos ,
Prestons Klassen ,
Preston Klassen ,
Nasdaq ,
Head Of Research ,
Prnewswire Regulus Therapeutics Inc ,
Rnas The Company Or Regulus ,
Arena Pharmaceuticals ,
Company Board Of Directors ,
University Of Nebraska Medical Center ,
Head Of Global Development At Orexigen Therapeutics ,
Regulus Therapeutics Inc ,
Head Of Research Development ,
Amgen ,
Regulus Therapeutics ,
Executive Vice President ,
Senior Vice President ,
Global Development ,
Executive Medical Director ,
Therapeutics Area Head ,
Nebraska Medical Center ,
Health Sciences ,
Duke University Medical ,
Dominant Polycystic Kidney Disease ,
vimarsana.com © 2020. All Rights Reserved.